52 | Proteins (Proteins, Gene)FDA Link
12/2022
-
03/2002 |
25 | Biomarkers (Surrogate Marker)IBA
10/2022
-
07/2005 |
21 | VaccinesIBA
11/2022
-
07/2005 |
21 | Biological ProductsIBA
04/2020
-
05/2002 |
18 | AntigensIBA
04/2022
-
05/2002 |
15 | MicroRNAs (MicroRNA)IBA
01/2022
-
09/2008 |
15 | Messenger RNA (mRNA)IBA
01/2021
-
03/2002 |
13 | Peptides (Polypeptides)IBA
01/2022
-
09/2014 |
13 | Long Noncoding RNAIBA
01/2022
-
01/2015 |
11 | Pharmaceutical PreparationsIBA
12/2022
-
06/2014 |
11 | Glucose (Dextrose)FDA LinkGeneric
01/2022
-
10/2009 |
11 | CytokinesIBA
11/2021
-
08/2002 |
10 | Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2021
-
01/2011 |
10 | Antiviral Agents (Antivirals)IBA
01/2020
-
11/2008 |
8 | ChemokinesIBA
01/2022
-
08/2002 |
8 | RNA (Ribonucleic Acid)IBA
01/2021
-
01/2010 |
7 | LigandsIBA
04/2022
-
07/2015 |
7 | Therapeutic UsesIBA
04/2022
-
01/2011 |
7 | Glycoproteins (Glycoprotein)IBA
01/2022
-
09/2009 |
6 | Radioisotopes (Radionuclides)IBA
01/2022
-
06/2017 |
6 | InterferonsIBA
01/2022
-
04/2005 |
6 | DNA (Deoxyribonucleic Acid)IBA
10/2020
-
09/2004 |
6 | Anti-Bacterial Agents (Antibiotics)IBA
01/2019
-
10/2006 |
6 | Peptide Hydrolases (Proteases)FDA Link
02/2014
-
12/2002 |
5 | Reactive Oxygen Species (Oxygen Radicals)IBA
12/2022
-
01/2015 |
5 | Immune Checkpoint InhibitorsIBA
04/2022
-
11/2018 |
5 | 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
01/2022
-
01/2016 |
5 | Sorafenib (BAY 43-9006)FDA Link
01/2022
-
04/2015 |
5 | 1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA
01/2022
-
01/2018 |
5 | CollagenIBA
01/2022
-
02/2014 |
5 | Melanins (Melanin)IBA
01/2021
-
12/2008 |
5 | Complement System Proteins (Complement)IBA
01/2021
-
08/2010 |
5 | ErbB Receptors (EGF Receptor)IBA
01/2021
-
01/2012 |
5 | AntibodiesIBA
12/2019
-
11/2014 |
5 | Insulin (Novolin)FDA Link
06/2016
-
10/2009 |
5 | Caveolin 1IBA
11/2008
-
07/2004 |
4 | Angiotensin-Converting Enzyme 2IBA
07/2022
-
10/2007 |
4 | AntioxidantsIBA
05/2022
-
01/2022 |
4 | Immunoglobulin G (IgG)IBA
01/2022
-
05/2002 |
4 | Brain-Derived Neurotrophic Factor (BDNF)IBA
11/2021
-
03/2008 |
4 | OvalbuminIBA
06/2021
-
07/2005 |
4 | Trastuzumab (Herceptin)FDA Link
01/2021
-
11/2018 |
4 | EnzymesIBA
01/2021
-
03/2015 |
4 | Somatostatin Receptors (Somatostatin Receptor)IBA
01/2021
-
06/2017 |
4 | EpitopesIBA
11/2020
-
01/2016 |
4 | Neutralizing AntibodiesIBA
01/2020
-
01/2014 |
4 | LipidsIBA
08/2019
-
10/2009 |